ExpressCells
Philadelphia
About ExpressCells
ExpressCells is a biotechnology company that uses genetic engineering to create custom cell lines for biological research and drug discovery. The company's primary focus is on creating research tools that will speed drug discovery and provide better disease models for basic researchers. ExpressCells was established by Oscar Perez-Leal and Matt Handel in 2018 and is headquartered in Philadelphia, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Last round: Series Unknown (Oct 2020)
- Website: xpresscells.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/expresscells-13609 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.